Mayordomo, Laramie D.
HRN: 16-09-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2022
CEFUROXIME 500MG (TAB)
04/30/2022
05/06/2022
PO
500mg
BID X 7 Days
UTI; Pus Cells: 6-9; Bacteria: Moderate; WBC: 15.8
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes